A Case-Control Study of Negative Pressure Platform Wound Devices (NP-PWD) for Skin and Soft Tissue Defects

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

28 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-08-16

Study Completion Date

2024-04-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will demonstrate the effectiveness of the NP-PWD therapy in managing complex wounds and improving wound healing parameters as compared to standard of care.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Negative Pressure Wound Therapy Registry

NCT02467998

Diabetic Foot Ulcers Venous Stasis Ulcer Pressure Ulcer +3 more

UNKNOWN

A Study Comparing V.A.C. Negative Pressure Wound Therapy (NPWT) to Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Amputation Wounds

NCT00837096

Diabetic Amputation Foot Wound

TERMINATED NA

The Study of Wound Dressings for Portable NPWT

NCT03135964

Pressure Ulcer Diabetic Foot Ulcer

COMPLETED NA

NPWTi on Closure of Chronic Pressure Sores

NCT05598398

Pressure Sore

RECRUITING PHASE4

Effect of Negative Pressure Wound Therapy After Surgical Removal of Deep-Seated High-Malignant Soft Tissue Sarcomas of the Extremities and Trunk Wall.

NCT04960332

Sarcoma Cancer Neoplasms, Connective and Soft Tissue

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A study of 24 completed subjects will be conducted by enrolling patients who are requiring treatment for open skin and soft tissue defects. Patients will be screened for inclusion criteria and asked to consent to participate in the study. Following consent subjects will be randomized to receive treatment of one of the two study arms. Arm 1, the standard of care arm, will receive KCI Wound VAC Granulofoam. Arm 2, the study arm, will receive treatment with NP-PWD. Prior to the initial application, wound evaluations and photography will be completed to include assessment of infection with wound swabs. The wound dressing will be assessed for the need for change every 2-3 days and changed if clinically indicated (following each device IFU). Subjects will be followed for up to nine days post initial application. At minimum, the randomized treatment will be applied for 2 days after initial application for a subject to be considered completed. Subject who do not complete the treatment course (minimum of 2 days of treatment), may be replaced per investigators discretion. Follow up data will be gathered at each change/removal of the NP-PWD or Wound VAC. The data collected will include indications for dressing change, dressing change process, photographs and assessments for wound healing, infection, and adverse events. Gathered clinical data of the enrolled subjects will be used to evaluate the feasibility in using the NP-PWD device for wound healing management.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Skin Wound Soft Tissue Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NP-PWD application

Patients randomized to NP-PWD arm will have the NP-PWD device applied to their wound.

Group Type EXPERIMENTAL

NP-PWD

Intervention Type DEVICE

Application of NP-PWD device.

Standard of Care Wound VAC application

Patients randomized to the standard of care arm will have the standard wound vac device applied to their wound.

Group Type ACTIVE_COMPARATOR

Wound Vac

Intervention Type DEVICE

Application of wound vac device.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NP-PWD

Application of NP-PWD device.

Intervention Type DEVICE

Wound Vac

Application of wound vac device.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

All subjects enrolled must meet ALL the following criteria:

1. Patients 18 years of age or older of either gender
2. Have an open skin or soft tissue defect requiring treatment

Exclusion Criteria

Subjects who meet any of the following criteria will be excluded from the study:

1. Active malignant disease at the study site
2. Any concomitant medications or co-morbidities that, in the opinion of the investigator, may interfere with device use
3. On any investigational drug(s) or therapeutic device(s) to the study site in the last 30 days or any previous enrollment in this study
4. Pregnant at enrollment

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No